KalVista Pharmaceuticals (KALV) EBT Margin (2014 - 2025)
KalVista Pharmaceuticals (KALV) reported EBT Margin of 115.88% for Q3 2025, up 75.99% sequentially from 482.55% in Q2 2025.
KalVista Pharmaceuticals (KALV) EBT Margin (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 8 years of EBT Margin data on file, last reported at 115.88% in Q3 2025.
- For the quarter ending Q3 2025, EBT Margin changed N/A year-over-year to 115.88%; the trailing twelve-month figure through Jul 2025 stood at 313.96% (up 53480.0% YoY), and the FY2025 full-year result was 1636.84%, down 153151.0% from the prior year.
- EBT Margin rose to 115.88% in Q3 2025, from 482.55% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 115.88% in Q3 2025 to a low of 482.55% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -115.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -115.88% |
| Apr 30, 2025 | -482.55% |
| Apr 30, 2020 | -196.78% |
| Jan 31, 2020 | -920.48% |
| Oct 31, 2019 | -275.05% |
| Jul 31, 2019 | -288.25% |
| Apr 30, 2019 | -378.09% |
| Jan 31, 2019 | -161.03% |
| Oct 31, 2018 | -89.65% |
| Jul 31, 2018 | -194.92% |
| Apr 30, 2018 | -60.00% |
| Jan 31, 2018 | -195.50% |
| Oct 31, 2017 | -546.67% |
| Jul 31, 2017 | -6,212.50% |
| Apr 30, 2017 | -4,458.45% |
| Jan 31, 2017 | -3,270.16% |
| Oct 31, 2016 | -2,038.07% |
| Jul 31, 2016 | -523.69% |
| Mar 31, 2016 | -102,342.86% |
| Dec 31, 2015 | -80,800.00% |